Analysis of 24-hour urine parameters as it relates to age of onset of cystine stone formation

Journal of Endourology

Volumn 24, Issue 7, 2010, Pages 1179-1182

  Lambert, Erica H ^a   Asplin, John R ^b   Herrell, Stanley Duke ^a   Miller, Nicole L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b LithoLink Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTINE;

ADULT; ARTICLE; CONTROLLED STUDY; CYSTINURIA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STONE FORMATION; URINALYSIS; URINE; URINE VOLUME;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CYSTINE; CYSTINURIA; FEMALE; HUMANS; INFANT; KIDNEY CALCULI; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 77954942384     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2010.0133     Document Type: Article

References (13)

1. Pak CYC, Fuller CJ. Assessment of cystine solubility in urine and of heterogeneous nucleation. J Urol 1983;129:1066-1070.
2. Polinsky MS, Kaiser BA, Baluarte HJ. Urolithiasis in childhood. Pediatr Clin North Am 1987;34:683-710.
3. Leusmann DB, Blaschke R, Schmandt W. Results of 5035 stone analysis: A contribution to epidemiology of urinary stone disease. Scan J Urol Nephrol 1990;24:205-210.
4. Worcester E, Parks JH, Josephson MA, et al. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 2003;64:2204-2213.
5. Nakagawa Y, Coe FL. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta 1999;289:57-68.
6. Nakagawa Y, Asplin JR, Goldfarb DS, et al. Clinical use of cystine supersaturation measurements. J Urol 2000;164: 1481-1485.
7. Palacin M, Goodyear P, Nunes V, et al. Cystinuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases. New York: McGraw Hill, 2001, pp. 4909-4932.
8. Rosenberg LE, Downing S, Durant JL, et al. Cystinuria: Biochemical evidence for three genetically distinct diseases. J Clin Invest 1966;45:365-371.
9. Dello SL, Pras E, Pontesilli C, et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: A need for a new classification. J Am Soc Nephrol 2002;13: 2547-2553.
10. Sakhaee K, Poindexter JR, Pak CY. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis. J Urol 1989;141:819-821.
11. Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. J Urol 2006;176:600-603.
12. Pietrow PK, Pope JC 4th, Adams MC, et al. Clinical outcome of pediatric stone disease. J Urol 2002;167:670-673.
13. Pietrow PK, Auge BK, Wizer AZ, et al. Durability of the medical management of cystinuria. J Urol 2003;169:68-70.